A Stanford Biodesign Program Development Partner Japan Biodesign

A Stanford Biodesign Program Development PartnerJapan Biodesign

Program Overview

Biodesign

Biodesign was launched by Dr. Paul Yock and other members of Stanford University in 2001 as a development and training program for talents who will lead innovations in medical devices based on Design-Thinking approach. The program develops solutions to various problems, using the needs in the clinical site as the starting point while verifying the perspective of commercialization from the initial stages of development, and is characterized by approaches that make innovation a reality.
Applications are sent from around the world to participate in a course lasting approximately one year, called “Fellowship.” Competition is fierce, with more than eighteen times competition rate, and only eight candidates are selected each year. Forty companies were started up during the 14-year period, and applications for over 400 patents were filed. In addition, over 500,000 patients receive benefits from devices that were created through this program. The program has already been introduced to India, Singapore, Ireland and the UK, and their introduction is currently being studied in countries all over the world.

BIODESIGN

BIODESIGN The Process of Innovating Medical Technologies,Yock.Petal.より

A Stanford Biodesign Program Development PartnerJapan Biodesign

Osaka University, The University of Tokyo and Tohoku University concluded program-development partnership with Stanford University in order to establish Japan Biodesign. With implementing entities being made up of Osaka University’s Graduate School of Medicine and the Global Center for Medical Engineering and Informatics, The University of Tokyo’s Medical Innovation Initiative, and Tohoku University Graduate School of Biomedical Engineering, Japan Biodesign cooperates with Biodesign Japan to conduct Fellowship, Classes and various seminars.